Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor

H Mano1, Y Hakeda, M Kumegawa

  • 1Department of Bioscience, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya, Tokyo, 156-8502, Japan, h-mano@nodai.ac.jp.

Cytotechnology
|November 13, 2008
PubMed

Insights

Estrogen directly inhibits bone loss in post-menopause by acting on mature osteoclasts. This effect is mediated by the estrogen receptor alpha (ERα), highlighting a key mechanism in osteoporosis.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Cell Biology

Background:

  • Menopause-associated estrogen decline accelerates bone loss, leading to osteoporosis.
  • The precise mechanisms regulating bone-resorbing osteoclasts during estrogen deficiency are not fully understood.

Purpose of the Study:

  • To investigate the direct function of estrogen and its receptors in mature osteoclasts.
  • To elucidate the role of estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) in estrogen's effect on osteoclast activity.

Main Methods:

  • Purified mature rabbit osteoclasts were used to assess bone resorption.
  • Reverse transcription-polymerase chain reaction (RT-PCR) was employed to detect estrogen receptor expression.
  • Antisense oligodeoxynucleotides targeting ERα were used to block receptor function.

Main Results:

  • Estrogen was found to directly inhibit the bone-resorbing activity of mature osteoclasts.
  • Mature osteoclasts expressed nuclear estrogen receptor alpha (ERα) but not ERβ.
  • Blocking ERα with antisense oligodeoxynucleotides abolished the inhibitory effect of estrogen on osteoclast bone resorption.

Conclusions:

  • Estrogen directly inhibits the bone-resorbing activity of mature osteoclasts.
  • Estrogen receptor alpha (ERα) mediates this direct inhibitory effect.
  • These findings contribute to understanding the pathogenesis of osteoporosis and potential therapeutic targets.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...